Hubbry Logo
Peptide hormonePeptide hormoneMain
Open search
Peptide hormone
Community hub
Peptide hormone
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Peptide hormone
Peptide hormone
Peptide hormone
View on Wikipedia
from Wikipedia
Illustration showing the binding of a peptide hormone to a cell receptor

Peptide hormones are hormones composed of peptide molecules. These hormones influence the endocrine system of animals, including humans.[1] Most hormones are classified as either amino-acid-based hormones (amines, peptides, or proteins) or steroid hormones. Amino-acid-based hormones are water-soluble and act on target cells via second messenger systems, whereas steroid hormones, being lipid-soluble, diffuse through plasma membranes to interact directly with intracellular receptors in the cell nucleus.

Like all peptides, peptide hormones are synthesized in cells from amino acids based on mRNA transcripts, which are derived from DNA templates inside the cell nucleus. The initial precursors, known as preprohormones, undergo processing in the endoplasmic reticulum. This includes the removal of the N-terminal signal peptide and, in some cases, glycosylation, yielding prohormones. These prohormones are then packaged into secretory vesicles, which are stored and released via exocytosis in response to specific stimuli, such as an increase in intracellular Ca2+ and cAMP levels.[2]

Prohormones often contain extra amino acid sequences necessary for proper folding but not for hormonal activity. Specific endopeptidases cleave the prohormone before secretion, producing the mature, biologically active hormone. Once in the bloodstream, peptide hormones travel throughout the body and bind to specific receptors on target cell membranes.

Some neurotransmitters are secreted and released in a manner similar to peptide hormones, and certain "neuropeptides" function as both neurotransmitters in the nervous system and hormones in the bloodstream.

When a peptide hormone binds to its receptor on the cell surface, it activates a second messenger within the cytoplasm, triggering signal transduction pathways that lead to specific cellular responses.[3]

Certain peptides, such as angiotensin II, basic fibroblast growth factor-2, and parathyroid hormone-related protein, can also interact with intracellular receptors in the cytoplasm or nucleus through an intracrine mechanism.[4]

Partial list of peptide hormones in humans

[edit]
  1. Adrenocorticotropic hormone (ACTH)
  2. Adropin
  3. Amylin
  4. Angiotensin
  5. Atrial natriuretic peptide (ANP)
  6. Calcitonin
  7. Cholecystokinin (CCK)
  8. Gastrin
  9. Ghrelin
  10. Glucagon
  11. Glucose-dependent insulinotropic polypeptide (GIP)
  12. Glucagon-like peptide-1 (GLP-1)
  13. Growth hormone
  14. Follicle-stimulating hormone (FSH)
  15. Human chorionic gonadotropin (hCG)
  16. Insulin
  17. Leptin
  18. Luteinizing hormone (LH)
  19. Melanocyte-stimulating hormone (MSH)
  20. Orexin/Hypocretin
  21. Oxytocin
  22. Parathyroid hormone (PTH)
  23. Prolactin
  24. Renin
  25. Somatostatin
  26. Thyroid-stimulating hormone (TSH)
  27. Thyrotropin-releasing hormone (TRH)
  28. Vasopressin, also called arginine vasopressin (AVP) or anti-diuretic hormone (ADH)
  29. Vasoactive intestinal peptide (VIP)
  30. Somatotropin (GH1)
  31. Gonadotropin Releasing Hormone 1 (GNRH1)
  32. Gonadotropin Releasing Hormone 2 (GNRH2)
  33. Growth Hormone Releasing Hormone (GHRH)
  34. Parathyroid Hormone Like Hormone (PTHLH)
  35. Corticotropin Releasing Hormone (CRH)
  36. Anti-Müllerian Hormone (AMH)
  37. Chorionic Somatomammotropin Hormone 1 (CSH1)
  38. Chorionic Somatomammotropin Hormone 2 (CSH2)
  39. Pro-Melanin Concentrating Hormone (PMCH)
  40. Resistin (RETN)

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Peptide hormone

View on Grokipedia
from Grokipedia
Peptide hormones are a diverse class of water-soluble signaling molecules composed of short to medium-length chains of , typically ranging from 3 to 200 residues, linked together by peptide bonds. These hormones are synthesized in endocrine glands or specialized cells and secreted into the bloodstream, where they travel to target tissues to elicit specific physiological responses by binding to cell surface receptors, such as G-protein-coupled receptors or receptor tyrosine kinases. Unlike lipid-soluble steroid hormones, which penetrate cell membranes to interact with intracellular receptors, peptide hormones cannot cross the plasma membrane and instead initiate signaling cascades that influence processes like , growth, and . The structure of peptide hormones varies widely, from simple nonapeptides like oxytocin and antidiuretic hormone (ADH), which feature a bridge for stability, to larger proteins such as insulin (51 organized into two chains linked by disulfide bonds) and (approximately 191 ). Synthesis begins with transcription of a into mRNA, followed by into a preprohormone on ribosomes; this precursor is then processed in the and Golgi apparatus, where signal peptides are cleaved and the is packaged into secretory vesicles for release via in response to stimuli like neural or hormonal signals. Many peptide hormones, including those in the glycoprotein family (e.g., [TSH], [FSH], and [LH]), undergo post-translational modifications such as to enhance their stability and bioactivity. Peptide hormones play critical roles in regulating a broad array of bodily functions, including glucose metabolism (via insulin and ), fluid balance and (via ADH and natriuretic peptides), reproduction and lactation (via oxytocin and ), and stress responses (via [ACTH] from the pro-opiomelanocortin [POMC] precursor). For instance, insulin promotes in cells to maintain , while counters this by stimulating during . Their actions are often paracrine or endocrine, contributing to tissue growth, differentiation, and survival, and dysregulation of these hormones is implicated in disorders such as diabetes mellitus and growth abnormalities.

Overview and Characteristics

Definition

Peptide hormones are short chains of , typically ranging from 3 to 200 residues in length, that are synthesized as larger precursor proteins and subsequently processed into their active forms through cleavage by proteases. These hormones are hydrophilic and circulate in the bloodstream to target distant cells, where they initiate signaling cascades. Unlike hormones, which are derived from and can readily cross cell membranes to bind intracellular receptors, peptide hormones cannot penetrate the plasma membrane and thus require surface receptors for action. hormones, in contrast, originate from single such as or and display variable , with some like catecholamines being water-soluble and others like being lipid-soluble. The identification of peptide hormones began in the early 20th century, with insulin serving as a seminal example; it was isolated in by and Charles Best through experiments involving pancreatic extracts from dogs, marking a breakthrough in understanding treatment. Numerous distinct peptide hormones have been identified in humans, playing essential roles in regulating processes including , , and stress response.

Key Properties

Peptide hormones exhibit high water solubility owing to their polar backbones, characterized by the amide linkages that form hydrophilic bonds. This property facilitates their transport in the bloodstream but results in short circulatory half-lives, typically ranging from minutes to hours, due to rapid degradation by circulating peptidases and proteases. Their water-soluble nature precludes diffusion across the of cell membranes, necessitating binding to extracellular receptors on the target cell surface to initiate signaling. hormones display considerable diversity in size, spanning oligopeptides with 3–10 residues, such as (TRH) with its three-residue structure, to larger polypeptides exceeding 20 residues, exemplified by insulin comprising 51 . Regarding stability, peptide hormones demonstrate resistance to elevated temperatures because of the thermal stability of peptide bonds, yet they remain sensitive to pH variations and particularly vulnerable to enzymatic cleavage, which contributes to their transient presence .

Biosynthesis and Processing

Synthesis Pathway

Peptide hormones are produced in specialized endocrine cells via a conserved biosynthetic pathway that mirrors general protein synthesis but incorporates elements of the regulated secretory pathway for precise control over release. The process initiates with the transcription of pre-prohormone genes in the nucleus, generating (mRNA) that encodes precursor proteins containing an N-terminal , the sequence, and often additional peptides or cleavage sites. This mRNA is then exported to the and translated by ribosomes bound to the rough (ER), yielding the pre-prohormone as a linear polypeptide chain. As the pre-prohormone is translocated into the ER lumen co-translationally, the —typically 15-30 long—is rapidly cleaved by signal peptidase, converting the precursor into the inactive . The folds within the ER, facilitated by chaperones, and is packaged into COPII-coated vesicles for transport to the cis-Golgi. Here, it progresses through the Golgi stack, where sorting signals, such as dibasic motifs or acidic residues in the , direct it to the trans-Golgi network (TGN) for concentration into immature secretory granules. In the TGN, prohormones like pro-opiomelanocortin (POMC) are selectively packaged into clathrin-coated regions, forming nascent secretory vesicles that mature into dense-core granules through acidification and condensation. These granules are transported along to the plasma membrane, where they remain stored until a stimulus, such as elevated intracellular calcium, triggers fusion and , releasing the prohormone or its derived peptides into the for circulation. This synthesis pathway exhibits evolutionary conservation across vertebrates, with homologous genes and machinery evident in mammals, reflecting adaptations from ancestral protein mechanisms to support endocrine signaling; for instance, the sorting motif in POMC's N-terminal region is shared with precursors like proinsulin.

Post-Translational Modifications

hormones undergo essential post-translational modifications (PTMs) in the secretory pathway to achieve their mature, bioactive forms from prohormone precursors. These modifications, primarily occurring in the (ER), Golgi apparatus, and secretory granules, include proteolytic cleavage, amidation, glycosylation, and bond formation, which are crucial for structural integrity, stability, and receptor binding affinity. A key PTM is proteolytic cleavage mediated by endopeptidases such as prohormone convertases PC1/3 and PC2, which excise active peptides from larger s at specific dibasic or monobasic residues. PC1/3 predominates in the regulated secretory pathway of endocrine cells, cleaving precursors like proinsulin and proglucagon, while PC2 often acts sequentially to refine products further. For instance, in the processing of (POMC), these enzymes generate multiple hormones including ACTH and . Tissue-specific variations in cleavage patterns arise from differential expression of these convertases; in the , PC1/3 primarily yields ACTH from POMC, whereas the and express both PC1/3 and PC2, producing additional peptides like α-MSH. C-terminal amidation, another vital modification, enhances peptide stability against exopeptidases and is catalyzed by peptidylglycine α-amidating monooxygenase (PAM), a bifunctional that first hydroxylates the glycine-extended precursor and then cleaves to form the . This PTM is essential for about half of all mammalian hormones, including calcitonin, where amidation at the is required for full in calcium regulation. PAM operates in the trans-Golgi network and secretory granules, ensuring amidated products are packaged for release. Glycosylation and disulfide bond formation further diversify and stabilize peptide hormones. N- or O-linked glycosylation, involving the addition of moieties to or serine/ residues, modulates folding, trafficking, and ; for example, O-glycosylation occurs on hormones like (GLP-1) and , influencing their bioactivity. bonds, formed between residues via oxidation in the ER, create structural loops critical for conformation; in insulin, three disulfide bridges link the A and B chains of proinsulin, enabling proper folding before proteolytic excision of the . These covalent linkages prevent aggregation and maintain receptor-binding potency.

Classification

By Chain Length

Peptide hormones are classified by their chain length, defined as the number of residues, which directly impacts their , stability, transport, and interaction with receptors. This structural categorization typically divides them into very short s, short to medium peptides, and larger polypeptides, reflecting common biological distributions rather than rigid boundaries. Very short s often consist of a few residues and function in rapid neural signaling. A representative example is , an 11-residue that mediates , perception, and by binding to neurokinin-1 receptors. These compact structures enable quick synthesis from precursor proteins and facile diffusion across synaptic clefts. Short to medium peptides typically regulate metabolic processes through endocrine signaling. , with 29 residues, exemplifies this category; it is secreted by pancreatic alpha cells to elevate blood glucose levels by stimulating hepatic and . Such peptides balance simplicity in production with sufficient size for specific receptor docking. Larger polypeptides exert broader systemic effects, often requiring cleavage from extensive prohormones. , comprising 191 residues, promotes anabolic processes including tissue growth, protein synthesis, and via activation of the . These extended chains support diverse secondary and tertiary structures essential for stability and multifunctionality. Chain length carries key structural implications: shorter peptides diffuse more rapidly through biological fluids due to lower molecular weight and reduced steric hindrance, facilitating paracrine actions, but they exhibit quicker enzymatic degradation by proteases, yielding half-lives often under 5 minutes. In contrast, longer polypeptides demand intricate folding mechanisms, including bond formation and hydrophobic core stabilization, to attain bioactive conformations, though this enhances resistance to and extends circulatory persistence. Across lengths, peptide hormones maintain high owing to their predominance of polar and charged , enabling aqueous transport without carriers.

By Functional Categories

Peptide hormones are often classified by their primary physiological roles, which encompass of , growth and development, stress responses, and , among others. This functional highlights how these hormones coordinate diverse bodily processes through specific signaling pathways, with examples drawn from key representatives in human physiology. Such categorization emphasizes their targeted actions rather than structural features, though variations in chain length can occur within groups. A prominent category involves metabolic regulators, which maintain energy balance and nutrient . Insulin, a 51-amino-acid produced by pancreatic beta cells, promotes into cells and inhibits hepatic glucose production to lower sugar levels during fed states. In opposition, , a 29-amino-acid secreted by pancreatic alpha cells, stimulates and in the liver to elevate glucose during , ensuring stable energy availability. These hormones exemplify the antagonistic yet complementary roles in glucose , with insulin exerting anabolic effects and catabolic ones. Another major functional group comprises hormones involved in growth and development, which drive tissue proliferation and maturation. (GH), a 191-amino-acid from the , stimulates somatic growth by promoting protein synthesis, , and chondrocyte proliferation in growth plates. It acts largely through insulin-like growth factors (IGFs), particularly IGF-1, a 70-amino-acid produced mainly in the liver, which mediates GH's effects on and in muscles and bones. Together, the GH-IGF axis orchestrates longitudinal growth and metabolic adaptations during development, with IGF-1 also exerting direct paracrine and autocrine influences on target tissues. Peptide hormones also play critical roles in stress responses and , enabling adaptation to environmental challenges. (ACTH), a 39-amino-acid derived from the , triggers the release of from the in response to stress, enhancing , immune modulation, and cardiovascular function to mobilize energy reserves. hormone (ADH), also known as , a nine-amino-acid from the , regulates water retention by increasing expression in renal collecting ducts, thereby maintaining plasma osmolality and blood volume during or osmotic stress. These hormones facilitate rapid physiological adjustments, with ACTH focusing on systemic stress coping and ADH on . Overlaps and multifunctionality are common among peptide hormones, arising from shared biosynthetic precursors that yield multiple bioactive products. For instance, ACTH is processed from (POMC), a large precursor also generating melanocyte-stimulating hormones (MSHs) and beta-endorphin, allowing coordinated influences on stress, pigmentation, and analgesia within the same neuroendocrine axis. This polyprotein strategy enables versatile signaling, where a single precursor supports diverse functions across systems like the hypothalamic-pituitary-adrenal pathway.

Mechanism of Action

Receptor Interactions

Peptide hormones exert their effects by binding to specific cell surface receptors, primarily G-protein-coupled receptors (GPCRs) or receptor tyrosine kinases (RTKs), due to their hydrophilic nature that prevents membrane permeation. Many peptide hormones, such as and , interact with class B GPCRs, where the hormone's C-terminal region binds to the receptor's extracellular domain (ECD) with high affinity, while the N-terminal region engages the to initiate activation. In contrast, hormones like insulin bind to RTKs, where attachment to the pre-dimerized receptor ectodomain induces a conformational shift that activates the intracellular kinase domains, often involving transphosphorylation without further dimerization. The specificity of these interactions arises from complementary structural motifs between the peptide hormone and receptor binding sites, ensuring selective activation of target cells. For instance, in class B GPCRs, variable loops in the ECD provide hormone-specific recognition, as seen in the glucagon receptor's interaction with via hydrogen bonding and hydrophobic contacts. These high-affinity bindings typically exhibit dissociation constants (Kd) in the nanomolar range, such as approximately 0.3 nM for insulin to its receptor and 1-10 nM for to its GPCR, reflecting the physiological concentrations required for effective signaling. Receptor distribution is tissue-specific, concentrating in cells responsive to the hormone's actions; for example, receptors are predominantly expressed on hepatocytes, enabling targeted of hepatic glucose production. To maintain signaling , prolonged hormone exposure triggers desensitization mechanisms, including receptor by kinases such as G-protein-coupled receptor kinases (GRKs) for GPCRs or tyrosine kinases for RTKs, followed by β-arrestin recruitment and , which internalizes the receptor complex and attenuates further activation. This process prevents overstimulation and allows for receptor recycling or degradation, as observed in both GPCR and RTK systems.

Intracellular Signaling

Upon binding to their cell surface receptors, peptide hormones trigger intracellular signaling cascades that transduce the extracellular signal into diverse cellular responses, primarily through G protein-coupled receptors (GPCRs) or (RTKs). These pathways enable rapid amplification and regulation of the hormonal signal, leading to changes in enzyme activity, function, and . In GPCRs, ligand-bound receptors activate heterotrimeric G proteins, which dissociate into Gα and Gβγ subunits to modulate downstream effectors. For instance, the V2 receptor, a Gs-coupled GPCR, stimulates adenylate cyclase to increase intracellular cyclic AMP (cAMP) levels, which in turn activates (PKA) to phosphorylate target proteins involved in water reabsorption. Similarly, Gq-coupled GPCRs, such as the , activate (), generating inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG); IP3 induces calcium release from the endoplasmic reticulum, while DAG activates () to propagate signaling. RTK pathways, exemplified by the , involve ligand-induced conformational changes leading to autophosphorylation of tyrosine residues, creating docking sites for adaptor proteins like insulin receptor substrates (IRS). This recruits and activates (PI3K), leading to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) production and activation of the AKT pathway for metabolic regulation, or the (MAPK) cascade for cell growth and proliferation. A key feature of these pathways is signal amplification, where a single hormone-receptor complex can activate multiple G proteins or molecules, each catalyzing the production of numerous second messengers or events, thereby enabling a robust cellular response from a limited number of molecules.

Physiological Functions

Roles in

Peptide hormones play pivotal roles in regulating metabolic processes, particularly in maintaining balance and nutrient . Insulin, secreted by pancreatic beta cells in response to elevated glucose, promotes anabolic pathways essential for postprandial metabolism. It facilitates glucose uptake in and by inducing the translocation of glucose transporter 4 () to the plasma membrane, thereby enabling efficient cellular glucose entry for utilization. In the liver and muscle, insulin stimulates glycogen synthesis through activation of , converting excess glucose into storage form to prevent . Additionally, insulin inhibits and promotes , directing fatty acids toward storage in triglycerides to support long-term reserves. In contrast, , released from pancreatic alpha cells during or , counters insulin's effects to mobilize energy stores. It stimulates hepatic by upregulating enzymes such as and glucose-6-phosphatase, generating new glucose from non-carbohydrate precursors like and to sustain blood glucose levels. also promotes in the liver, breaking down stored into glucose for release into circulation. Concurrently, it enhances in adipocytes, liberating free fatty acids and as alternative fuels during energy deficits, thereby preserving glucose for glucose-dependent tissues like the . Leptin, an adipocyte-derived peptide hormone, integrates peripheral fat stores with central control to regulate long-term energy balance. Circulating levels reflect mass and signal to the , particularly the arcuate nucleus, to suppress and promote via inhibition of orexigenic neurons and activation of anorexigenic pathways. This hypothalamic modulation reduces food intake and increases energy expenditure, preventing excessive fat accumulation. By influencing and , maintains fat storage , ensuring adaptation to nutritional states without overreliance on acute glucose fluctuations. The interplay between these hormones exemplifies antagonistic regulation critical for metabolic . Insulin and operate in a reciprocal manner: insulin suppresses secretion while promoting glucose storage, whereas antagonizes insulin's actions to favor glucose production during , collectively stabilizing blood glucose within narrow limits. complements this by providing feedback on energy reserves, fine-tuning insulin and responses through hypothalamic integration to balance nutrient handling across fed and fasted states. This coordinated network prevents metabolic extremes, such as hypo- or , supporting overall energy equilibrium.

Roles in Reproduction and Growth

Peptide hormones play pivotal roles in regulating reproductive processes and somatic growth through precise coordination of cellular and physiological responses. In , they orchestrate production, , and parturition, while in growth, they drive tissue expansion and maturation primarily via endocrine axes. These functions are mediated by interactions with specific receptors on target cells, such as gonadal tissues and chondrocytes, ensuring developmental progression from through adulthood. Gonadotropins, including (FSH) and (LH), are essential peptide hormones secreted by the that stimulate and steroidogenesis in the gonads. In females, FSH promotes follicular development in the ovaries by enhancing proliferation and aromatization of androgens to estrogens, while LH triggers and supports formation for progesterone production. In males, FSH acts on Sertoli cells to foster , and LH stimulates Leydig cells to produce testosterone, which is crucial for spermatid maturation and secondary sexual characteristics. These actions ensure reproductive competence and fertility across sexes. Oxytocin, a nonapeptide synthesized in the and released from the , is critical for labor and in females. During parturition, it induces rhythmic contractions of uterine by binding to oxytocin receptors, facilitating and fetal expulsion. Postpartum, oxytocin triggers ejection by contracting myoepithelial cells in the mammary glands, enabling nutrient transfer to the offspring in response to suckling stimuli. This hormone's pulsatile release underscores its role in maternal reproductive physiology. Growth hormone (GH), a 191-amino-acid peptide from the , promotes linear growth predominantly through mediation by insulin-like growth factor-1 (IGF-1). GH stimulates the liver and local tissues to produce IGF-1, which binds to receptors on chondrocytes in the epiphyseal growth plate, enhancing their proliferation, , and matrix synthesis to elongate long bones. This IGF-1-dependent mechanism is vital for somatic growth during childhood and adolescence, with direct GH effects also supporting chondrocyte differentiation. Disruptions in this pathway can impair statural development. These reproductive and growth functions are tightly regulated by feedback loops within the hypothalamic-pituitary-gonadal (HPG) axis and related systems. (GnRH), a decapeptide from hypothalamic neurons, pulses to stimulate FSH and LH secretion, which in turn are modulated by gonadal steroids via to maintain . In growth regulation, GH release is influenced by hypothalamic peptides like growth hormone-releasing hormone (GHRH), integrating nutritional and stress signals to balance developmental demands. Such loops ensure adaptive responses to physiological needs.

Examples in Humans

Metabolic Hormones

Insulin is a peptide hormone consisting of 51 , synthesized and secreted by the beta cells of the in response to elevated blood glucose levels. It plays a central role in metabolic regulation by facilitating the uptake of glucose into cells, particularly muscle and , thereby lowering blood glucose concentrations and promoting anabolic processes such as synthesis and . Glucagon, a 29-amino-acid , is primarily produced by the of the and acts to counteract by stimulating hepatic and . This elevates blood glucose levels, ensuring energy availability during fasting or low-carbohydrate states, and also influences by promoting . Ghrelin, comprising 28 , is predominantly secreted by cells in the fundus and serves as a key regulator of energy balance. It stimulates by acting on hypothalamic centers and induces release from the , contributing to overall metabolic . Amylin, a 37-amino-acid , is co-secreted with insulin from pancreatic beta cells during meals to modulate postprandial glucose excursions. By slowing gastric emptying and suppressing secretion, it helps prevent rapid rises in blood glucose and enhances .

Neuroendocrine Hormones

Neuroendocrine hormones are hormones produced by neuroendocrine cells that release hormones into the blood in response to neural stimulation, often as part of the hypothalamic-pituitary axis, playing crucial integrative roles in coordinating neural signals with endocrine responses to maintain , stress adaptation, and social behaviors. Oxytocin, a nonapeptide consisting of 9 residues, is synthesized in the supraoptic and paraventricular nuclei of the and transported to the for storage and release. It facilitates social bonding by modulating neural circuits involved in and affiliative behaviors, such as pair bonding and maternal care, thereby integrating emotional and physiological responses in social interactions. , also known as antidiuretic hormone (ADH) and comprising 9 residues in a cyclic nonapeptide structure, is similarly produced in hypothalamic nuclei and released from the . It regulates water retention by promoting insertion in renal collecting ducts to enhance reabsorption, and it maintains through vasoconstrictive effects on vascular , thus integrating with cardiovascular . Adrenocorticotropic hormone (ACTH), a 39-amino-acid peptide derived from the posttranslational cleavage of pro-opiomelanocortin (POMC) in the anterior pituitary, stimulates cortisol production in the adrenal cortex by binding to melanocortin-2 receptors, activating cAMP-dependent pathways that drive glucocorticoid synthesis. This action integrates hypothalamic-pituitary signaling with the stress response, enabling adaptive adjustments to physiological challenges. Thyrotropin-releasing hormone (TRH), a tripeptide with 3 amino acid residues (pyroglutamyl-histidyl-prolinamide), is synthesized in paraventricular hypothalamic neurons and released into the hypophyseal portal system to stimulate thyrotropin (TSH) secretion from anterior pituitary thyrotrophs. By triggering TSH release, TRH regulates thyroid hormone production, integrating central nervous system control with peripheral thyroid function to support metabolism and growth.

Clinical and Research Significance

Associated Disorders

Dysregulation of peptide hormones, through deficiencies or excesses, can lead to a variety of endocrine disorders that disrupt normal physiological balance. Diabetes mellitus, a chronic , arises primarily from insulin deficiency or , resulting in persistent and impaired glucose utilization. In , autoimmune destruction of pancreatic beta cells leads to absolute insulin deficiency, while involves relative insulin deficiency combined with peripheral tissue resistance to insulin action. This can cause long-term complications such as , neuropathy, and if unmanaged. Growth disorders are frequently associated with dysregulation of (GH), a key peptide hormone regulating linear growth and . GH deficiency in children, often due to pituitary abnormalities, results in or characterized by growth failure below the third percentile for age and sex. Conversely, GH excess, typically from a , causes in children before epiphyseal closure or in adults, leading to excessive bone and soft tissue growth, enlarged facial features, and increased risk of and cardiovascular issues. Hypopituitarism involves partial or complete failure of the to secrete peptide hormones, including (ACTH) and (TSH), leading to downstream endocrine deficiencies. Reduced ACTH secretion impairs adrenal cortisol production, causing with symptoms like fatigue, hypotension, and electrolyte imbalances. Similarly, TSH deficiency results in secondary hypothyroidism, characterized by low thyroid hormone levels, slowed metabolism, and symptoms such as weight gain and cold intolerance. The syndrome of inappropriate antidiuretic hormone secretion (SIADH) stems from excessive (antidiuretic hormone, ADH) release, which promotes renal water reabsorption despite low , leading to dilutional . This euvolemic can manifest as , , , and in severe cases, seizures or due to . Common causes include disorders or malignancies, but the core involves non-osmotic ADH stimulation.

Therapeutic Applications

Peptide hormones and their synthetic analogs play a pivotal role in clinical medicine, particularly in managing endocrine disorders through targeted replacement or modulation of physiological signaling. Recombinant human insulin, produced via technology since the early 1980s, serves as a cornerstone for type 1 and mellitus, effectively lowering blood glucose levels to prevent hyperglycemia-related complications. Analogs such as , with its modified sequence for faster absorption, enable rapid-acting control of postprandial glucose spikes, improving glycemic management and reducing hypoglycemic events compared to regular human insulin. These formulations have transformed care by addressing limitations of animal-derived insulins, such as and supply shortages. Desmopressin, a synthetic analog of with enhanced selectivity, is widely used to treat by promoting renal water reabsorption and reducing excessive urine output. It is also effective for (bedwetting) in children, decreasing nighttime urine production and achieving response rates of up to 60-70% in clinical trials. (GnRH) agonists, such as leuprolide, provide therapeutic benefits in hormone-dependent conditions by initially stimulating and then downregulating GnRH receptors, leading to suppressed secretion and reduced sex steroid levels. Leuprolide is particularly applied in to alleviate pain and lesion growth, and in advanced to inhibit production, thereby slowing tumor progression. Despite their efficacy, peptide hormones face therapeutic challenges, including short plasma half-lives due to rapid enzymatic degradation and renal clearance, often necessitating frequent dosing. Strategies like —covalent attachment of —extend circulation time and , as seen in modified formulations that prolong insulin action. Long-acting depot injections, such as those for leuprolide, further mitigate this by providing sustained release over weeks or months. An example of successful oral delivery is (a GLP-1 analog), approved in 2019 using the permeation enhancer SNAC to improve absorption and patient compliance by bypassing injections. Ongoing research continues to address gastrointestinal barriers for broader oral applications. In 2024, the FDA approved additional peptide therapeutics, including palopegteriparatide for treating and pegulicianine for intraoperative detection of cancer margins, expanding clinical uses of peptide-based treatments.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK562260/
  2. https://www.ncbi.nlm.nih.gov/books/NBK541112/
  3. https://www.umassmed.edu/dcoe/diabetes-education/patient-resources/banting-and-best-discover-insulin/
  4. https://vivo.colostate.edu/hbooks/pathphys/endocrine/basics/chem.html
  5. https://bio.libretexts.org/Bookshelves/Introductory_and_General_Biology/General_Biology_(Boundless)/37:The_Endocrine_System/37.02:Types_of_Hormones_-_Lipid-Derived_Amino_Acid-Derived_and_Peptide_Hormones
  6. https://courses.lumenlearning.com/suny-ap2/chapter/hormones/
  7. https://www.yourhormones.info/hormones/thyrotropin-releasing-hormone/
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC9664347/
  9. https://www.sciencedirect.com/topics/medicine-and-dentistry/peptide-hormone-biosynthesis
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC4899099/
  11. https://www.ncbi.nlm.nih.gov/books/NBK279029/
  12. https://bioone.org/journals/zoological-science/volume-20/issue-10/zsj.20.1183/Comparative-Aspects-of-Intracellular-Proteolytic-Processing-of-Peptide-Hormone-Precursors/10.2108/zsj.20.1183.full
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC6170974/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC9177522/
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC7441158/
  16. https://www.ncbi.nlm.nih.gov/books/NBK554583/
  17. https://www.ncbi.nlm.nih.gov/books/NBK28247/
  18. https://pubchem.ncbi.nlm.nih.gov/compound/Glucagon
  19. https://www.ncbi.nlm.nih.gov/books/NBK482141/
  20. https://www.sciencedirect.com/topics/neuroscience/peptide-hormone
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC11115868/
  22. https://www.ncbi.nlm.nih.gov/books/NBK545201/
  23. https://www.ncbi.nlm.nih.gov/books/NBK279127/
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC1187088/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC2439518/
  26. https://www.ncbi.nlm.nih.gov/books/NBK500031/
  27. https://www.ncbi.nlm.nih.gov/books/NBK526069/
  28. https://www.ncbi.nlm.nih.gov/books/NBK279157/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC3410228/
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC4633518/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC3690506/
  32. https://www.ncbi.nlm.nih.gov/books/NBK378978/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC10398885/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC3820480/
  35. https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00413/full
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC5533627/
  37. https://www.nature.com/articles/s12276-020-0456-3
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC4021379/
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC9192144/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC3982941/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC7286536/
  42. https://www.ncbi.nlm.nih.gov/books/NBK525983/
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC8232639/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC3563428/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC6491692/
  46. https://www.ncbi.nlm.nih.gov/books/NBK537038/
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC8167040/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC8873071/
  49. https://diabetesjournals.org/spectrum/article/17/3/183/1994/Glucose-Metabolism-and-Regulation-Beyond-Insulin
  50. https://www.nature.com/articles/s41598-019-50889-4
  51. https://journals.physiology.org/doi/abs/10.1152/ajpendo.00492.2002
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC6129417/
  53. https://www.ncbi.nlm.nih.gov/books/NBK535442/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC3963304/
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC8658012/
  56. https://www.ncbi.nlm.nih.gov/books/NBK539692/
  57. https://www.ncbi.nlm.nih.gov/books/NBK507848/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC8578887/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC3235456/
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC7736189/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC7299241/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC5987361/
  63. https://www.ncbi.nlm.nih.gov/books/NBK279070/
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC5819073/
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC8735818/
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC4899204/
  67. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuroendocrine
  68. https://www.ncbi.nlm.nih.gov/books/NBK278989/
  69. https://www.ncbi.nlm.nih.gov/books/NBK551501/
  70. https://www.ncbi.nlm.nih.gov/books/NBK513253/
  71. https://www.ncbi.nlm.nih.gov/books/NBK278971/
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC2563724/
  73. https://www.mayoclinic.org/diseases-conditions/hypopituitarism/symptoms-causes/syc-20351645
  74. https://www.ncbi.nlm.nih.gov/books/NBK507777/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC8844085/
  76. https://pubmed.ncbi.nlm.nih.gov/17335298/
  77. https://www.ncbi.nlm.nih.gov/books/NBK554582/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC8984681/
  79. https://www.ncbi.nlm.nih.gov/books/NBK551662/
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC10201293/
  81. https://pmc.ncbi.nlm.nih.gov/articles/PMC10960368/
  82. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-first-oral-glp-1-treatment-type-2-diabetes
  83. https://www.mdpi.com/1424-8247/18/3/291
Add your contribution
Related Hubs
User Avatar
No comments yet.